Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedThe history shows an addition of 'Revision: v3.3.3' and removals of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' in the footer, which are site metadata updates rather than trial-specific content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision note (v3.3.2) and a 'Study Status' entry were added to the Record History, with the latest version counted as 32. The previous revision (v3.2.0) was removed.SummaryDifference0.4%

- Check37 days agoChange DetectedThe government funding lapse notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check51 days agoChange DetectedThe page's Record History section shows an updated version entry but no substantive changes to the study details, status, or locations.SummaryDifference0.1%

- Check65 days agoChange DetectedAdditions introduce a new date and updated study status/contacts/locations; deletion removes an older date marker, indicating an update to scheduling and contact information.SummaryDifference1%

- Check80 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed old version label v3.1.0.SummaryDifference11%

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.